Table 5 Prognostic implication of lymphocyte subpopulations
| Parameters | P value (Blood) n = 43 | P value (Tissue) n = 35 |
|---|---|---|
| Age (≤47 years Vs. > 47 years) | 0.755 | 0.979 |
| Stage (FIGO I Vs. ≥FIGO II) | 0.076 | 0.355 |
| Histology (SCC Vs. ADC) | 0.002# | 0.002# |
| Tumor (≤4 cm Vs. > 4 cm) | 0.214 | 0.032# |
| Stromal invasion (≤1/2 Vs. > 1/2) | 0.762 | 0.555 |
| LN metastasis (negative Vs. positive) | < 0.001# | 0.001# |
| LVSI (negative Vs. positive) | 0.017# | 0.034# |
| Gran %CD45 | 0.561 | 0.957 |
| T %MNC | 0.413 | 0.939 |
| CD4%T | 0.066 | 0.090 |
| CD8%T | 0.088 | 0.005# |
| CD4:CD8 | 0.048# | 0.008# |
| rdT %T | 0.294 | 0.317 |
| B %MNC | 0.544 | 0.513 |
| pDC % MNC | 0.727 | 0.278 |
| CD11c + % pDC | 0.576 | 0.509 |
| Baso % MNC | 0.528 | 0.591 |
| BDCA1+ mDC % MNC | 0.337 | 0.132 |
| BDCA3+ mDC % MNC | 0.632 | 0.371 |
| Mono %MNC | 0.808 | 0.812 |
| CD14+ Mo % MNC | 0.961 | 0.481 |
| CD16+ Mo % MNC | 0.576 | 0.062 |
| CD16+ %Mono | 0.576 | 0.062 |
| NK %MNC | 0.752 | 0.533 |
| CD56hi NK % MNC | 0.820 | 0.648 |
| CD56lo NK % MNC | 0.525 | 0.481 |
| CD56hi %NK | 0.525 | 0.563 |
| MDSC % CD33hi | 0.576 | 0.679 |
| DR- %14 + APC | 0.443 | 0.536 |
| DR- %16 + APC | 0.093 | 0.106 |